Roles of VCP in human neurodegenerative disorders

Biochemical Society Transactions

Volumn 36, Issue 1, 2008, Pages 105-108

  Kakizuka, Akira ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

Aggregate; ATPase; ATPase associated with various cellular activities (AAA); Inclusion body; Inclusion body myopathy; Neurodegeneration; Paget disease of bone and front temporal dementia (IBMPFD); Valosin containing protein (VCP)

Indexed keywords

ADENOSINE TRIPHOSPHATASE; FORMASE ENZYME; LUCIFERASE; POLYGLUTAMINE; UNCLASSIFIED DRUG; UNFOLDASE ENZYME; VALOSIN CONTAINING PROTEIN;

ARTICLE; BINDING AFFINITY; DEGENERATIVE DISEASE; ENZYME ACTIVITY; FRONTOTEMPORAL DEMENTIA; HELA CELL; HUMAN; INCLUSION BODY MYOSITIS; PAGET BONE DISEASE; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION;

ADENOSINE TRIPHOSPHATASES; CELL CYCLE PROTEINS; HUMANS; LUCIFERASES; MOLECULAR CHAPERONES; NEURODEGENERATIVE DISEASES; PROTEIN BINDING; PROTEIN DENATURATION;

EID: 39449116598     PISSN: 03005127     EISSN: None     Source Type: Journal    
DOI: 10.1042/BST0360105     Document Type: Article

References (20)

1. Kawaguchi, Y., Okamoto, T., Taniwaki, M., Aizawa, M., Inoue, M., Katayama, S., Kawakami, H., Nakamura, S., Nishimura, M., Akiguchi, I. et al. (1994) CAG expansions in a novel gene for Machado-Joseph disease at chromosome 14q32.1. Nat. Genet. 8, 221-228
2. Kakizuka, A. (1998) Protein precipitation: a common etiology in neurodegenerative disorders? Trends Genet. 14, 396-402
3. Kimura, Y. and Kakizuka, A. (2003) Polyglutamine diseases and molecular chaperones. IUBMB Life 55, 337-345
4. Ikeda, H., Yamaguchi, M., Sugai, S., Aze, Y., Narumiya, S. and Kakizuka, A. (1996) Expanded poly-glutamine in the Machado-Joseph disease protein induces cell death in vitro and in vivo. Nat. Genet. 13, 196-202
5. Yasuda, S., Inoue, K., Hirabayashi, M., Higashiyama, H., Yamamoto, Y., Fuyuhiro, H., Komure, O., Tanaka, F., Sobue, G., Tsuchiya, K. et al. (1999) Triggering of neuronal cell death by accumulation of activated SEK1 on nuclear polyglutamine aggregations in PML bodies. Genes Cells 4, 743-756
6. Kobayashi, T. and Kakizuka, A. (2003) Molecular analyses of Machado-Joseph disease. Cytogenet. Genome Res. 100, 261-275
7. Hirabayashi, M., Inoue, K., Tanaka, K., Nakadate, K., Ohsawa, Y., Kamei, Y., Popiel, A.H., Sinohara, A., Iwamatsu, A., Kimura, Y. et al. (2001) VCP/p97 in abnormal protein aggregates, cytoplasmic vacuoles, and cell death, phenotypes relevant to neurodegeneration. Cell Death Differ. 8, 977-984
8. Kobayashi, T., Tanaka, K., Inoue, K. and Kakizuka, A. (2002) Functional ATPase activity of p97/VCP is reguired for the guality control of endoplasmic reticulum in neuronally differentiated mammalian PC12 cells. J. Biol. Chem. 277, 47358-47365
9. Higashiyama, H., Hirose, F., Yamaguchi, M., Inoue, Y., Fujikake, N., Matsukage, A. and Kakizuka, A. (2002) Identification of ter94, Drosophila VCP, as a modulator of polyglutamine-induced neurodegenerations in Drosophila. Cell Death Differ. 9, 264-273
10. Boeddrich, A., Gaumer, S., Haacke, A., Tzvetkov, N., Albrecht, M., Evert, B. O., Müller, E.C., Lurz, R., Breuer, P., Schugardt, N. et al. (2006) An arginine/lysine-rich motif is crucial for VCP/p97-mediated modulation of ataxin-3 fibrillogenesis. EMBO J. 25, 1547-1558
11. Mizuno, Y., Hori, S., Kakizuka, A. and Okamoto, K. (2003) Vacuole-creating protein in neurodegenerative diseases. Neurosci. Lett. 343, 77-80
12. Ishigaki, S., Hishikawa, N., Niwa, J., Iemura, S., Natsume, T., Hori, S., Kakizuka, A., Tanaka, K. and Sobue, G. (2004) Physical and functional interaction between dorfin and valosin-containing protein that are colocalized in ubiquitylated inclusions in neurodegenerative disorders. J. Biol. Chem. 279, 51376-51385
13. Kobayashi, T., Manno, A. and Kakizuka, A. (2007) Involvement of valosin-containing protein (VCP)/p97 in the formation and clearance of abnormal protein aggregates. Genes Cells 12, 889-901
14. Kitami, M.I., Kitami, T., Nagahama, M., Tagaya, M., Hori, S., Kakizuka, A., Mizuno, Y. and Hattori, N. (2006) Dominant-negative effect of mutant valosin-containing protein in aggresome formation. FEBS Lett. 580, 474-478
15. Watts, G.D., Wymer, J., Kovach, M.J., Mehta, S.G., Mumm, S., Darvish, D., Pestronk, A., Whyte, M. P. and Kimonis, V. E. (2004) Inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia is caused by mutant valosin-containing protein. Nat. Genet. 36, 377-381
16. Haubenberger, D., Bittner, R.E., Rauch-Shorny, S., Zimprich, F., Mannhalter, C., Wagner, L., Mineva, I., Vass, K., Auff, E. and Zimprich, A. (2005) Inclusion body myopathy and Paget disease is linked to a novel mutation in the VCP gene. Neurology 65, 1304-1305
17. Forman, M.S., Mackenzie, I.R., Cairns, N.J., Swanson, E., Boyer, P.J., Drachman, D.A., Jhaveri, B.S., Karlawish, J.H., Pestronk, A., Smith, T.W. et al. (2006) Novel ubiquitin neuropathology in frontotemporal dementia with valosin-containing protein gene mutations. J. Neuropathol. Exp. Neurol. 65, 571-581
18. Leclerc, A., Tome, F.M. and Fardeau, M. (1993) Ubiquitin and β-amyloid-protein in inclusion body myositis (IBM), familial IBM-like disorder and oculopharyngeal muscular dystrophy: an immunocytochemical study. Neuromuscul. Disord. 3, 283-291
19. Murakami, N., Ishiguro, K., Ihara, Y., Nonaka, I., Sugita, H. and Imahori, K. (1995) Tau protein immunoreactivity in muscle fibers with rimmed vacuoles differs from that in regenerating muscle fibers. Acta Neuropathol. 90, 467-471
20. Askanas, V., Engel, W.K., Alvarez, R.B., McFerrin, J. and Broccolini, A. (2000) Novel immunolocalization of α-synuclein in human muscle of inclusion-body myositis, regenerating and necrotic muscle fibers, and at neuromuscular junctions. J. Neuropathol. Exp. Neurol. 59, 592-598